Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 47 Lung Neoplasms 25 Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasm Metastasis 6 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Mesothelioma, Malignant 3 Melanoma 3 Colonic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Non-squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma 2 Adenocarcinoma of Lung 2 Vaccinia 1 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1

Interventions

Cisplatin 6 pembrolizumab 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Fulvestrant 3 palbociclib 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiation Dose Hypofractionation 2 Radiation 2 Platinum 2 Paclitaxel 2 Fluorouracil 2 Fluorodeoxyglucose F18 2 Drug Therapy 2 Congresses as Topic 2 Carboplatin 2 Brachytherapy 2 Biopsy 2 Bevacizumab 2 Axitinib 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 1,2-diaminocyclohexaneplatinum II citrate 2 zimberelimab 1 ulixertinib 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 trametinib 1 tisotumab vedotin 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Pemetrexed × 30 days × Clear all

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡